Tunnah’s musings: pharma deals with the January pipeline blues
As 2012 gets under way it looks like big pharma has an appetite for spending money, but is buying up all the biotechs really going to deliver the innovation the industry needs? Whilst most of us are tightening our belts after another festive season, it seems like big pharma is in the mood for even more shopping in January…